GLUT1 protein expression correlates with unfavourable histologic category and high risk in patients with neuroblastic tumours

HIF-1α up-regulation is associated with adverse clinicopathological and biological factors in neuroblastomas

(2012) Josiah V Dungwa et al.   HISTOPATHOLOGY

Carbonic anhydrase IX up-regulation is associated with adverse clinicopathologic and biologic factors in neuroblastomas

(2012) Josiah V. Dungwa et al.   HUMAN PATHOLOGY

Glycolysis inhibitors as a potential therapeutic option to treat aggressive neuroblastoma expressing GLUT1

(2012) Kohei Matsushita et al.   JOURNAL OF PEDIATRIC SURGERY

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy

(2012) Gregg L. Semenza   TRENDS IN PHARMACOLOGICAL SCIENCES

Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review

(2011) Paolo E. Porporato et al.   Frontiers in Pharmacology

Combinatorial Regulation of Neuroblastoma Tumor Progression by N-Myc and Hypoxia Inducible Factor HIF-1 

(2010) G. Qing et al.   CANCER RESEARCH

Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma

(2010) Fernanda Rocha Rojas Ayala et al.   MOLECULES

Molecular pathogenesis of peripheral neuroblastic tumors

(2010) I Janoueix-Lerosey et al.   ONCOGENE

GLUT1 as a therapeutic target in hepatocellular carcinoma

(2009) Thomas Amann et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis

(2009) Adrian M. Jubb et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

(2008) Tom Monclair et al.   JOURNAL OF CLINICAL ONCOLOGY

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

(2008) Susan L. Cohn et al.   JOURNAL OF CLINICAL ONCOLOGY